ArticleJournal of neurology2026
Influence of preexisting cognitive impairment and comorbidities on post-stroke outcomes: Dijon Stroke Registry.
Article in Journal of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPoststroke outcomes remain highly variable, particularly in older and frailer patients with multiple comorbidities. This study aimed to evaluate the independent impact of prestroke cognitive status and comorbidities on one-year functional and vital outcomes.
methodsStroke patients (> 50 years old) were prospectively identified from the population-based Dijon Stroke Registry, France (2017-2022). Prestroke cognitive status (normal cognition, mild cognitive impairment (MCI), and dementia) and comorbidities were collected. Functional outcome (modified Rankin Scale) and survival were evaluated at 1 year. Multivariable logistic and Cox regression models were used to assess the associations between cognitive status and patient outcomes.
resultsAmong 1445 included patients (mean age 78.9 ± 12.0 years; 53.4% women), 907 (62.8%) had no prestroke cognitive impairment, 241 (16.7%) had MCI, and 297 (20.5%) had dementia. Patients with preexisting cognitive impairment were older and had a higher prevalence of vascular risk factors and comorbidities. One-year case-fatality was 25.7% in cognitively unimpaired patients, 35.3% in MCI patients, and 59.3% in patients with dementia. A poor functional outcome was observed in 49.9%, 66.2%, and 81.4% of patients, respectively. After adjustment for comorbidities, both MCI (OR = 1.45; 95% CI 1.01-1.81, p = 0.04) and dementia (OR = 2.65; 95% CI 1.81-3.87, p < 0.001) were associated with unfavorable functional outcomes. Furthermore, dementia was associated with increased 1-year death (HR = 1.98; 95% CI 1.60-2.48, p < 0.001).
conclusionsPreexisting cognitive impairment negatively influenced patient outcomes after stroke. The observed associations were independent of comorbid conditions, highlighting the importance of considering prestroke cognitive status in the design and interpretation of interventional studies aiming to improve stroke outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.